Viewing Study NCT01594918


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2026-03-31 @ 5:05 PM
Study NCT ID: NCT01594918
Status: COMPLETED
Last Update Posted: 2017-07-21
First Post: 2012-05-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer
Sponsor: Rahul Aggarwal
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module